Health promotion: A profitable investment? Economic efficiency of preventive interventions in Spain;Prevención en salud: ¿Inversión rentable? Eficiencia económica de las intervenciones preventivas en España

Gaceta Sanitaria

Volumn 21, Issue 2, 2007, Pages 150-161

  Esperato, Alexo ^a   García Altés, Anna ^a  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

Economic evaluation; Preventive intervention; Systematic review

Indexed keywords

EID: 34249861546     PISSN: 02139111     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101044     Document Type: Review

References (19)

1. Lalonde MA. New perspectives on the health of Canadians. A working document. Ottawa: Information Canada; 1974.
2. García-Altés A. Twenty years of health care economic analysis in Spain: are we doing well? Health Economics. 2001;10:715-29.
3. Oliva J, Del Llano J, Sacristán JA. Análisis de las evaluaciones eoonómicas de tecnologías sanitarias realizadas en España en la década 1990-2000. Gac Sanit. 2002;16 Supl 2:2-11.
4. Valderas JM, Mendivil J, Parada A, Losada-Yáñez M, Ferrer M, Alonso J. Construcción de un filtro geográfico para la identificación en Pubmed de estudios realizados en España. Rev Esp Cardiol. En prensa 2007.
5. Drummond MF, Stoddart GL, Torrance GW. Métodos de evaluación económica de los programas de atención de la salud. Madrid: Díaz de Santos; 1991.
6. Bell C, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greeenberg D, et al. Bias in published cost effectiveness studies: systematic review. BMJ. 2006;332:699-703.
7. Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA. 1999;282:1453-7.
8. Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods SW. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry. 2003; 183:498-506.
9. Elixhauser A, Halpern M, Schmier J, Luce BR. Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med Care. 1998;36:1MS-9MS.
10. Elixhauser A, Luce BR, Taylor WR, Reblando J. Health care CBA/CEA: an update on the growth and composition of the literature. Med Care. 1993;31:1JS-11JS.
11. Rush B, Shiell A, Hawe P. A census of economic evaluations in health promotion. Health Educ Res. 2004;19:707-19.
12. Sacristán JA, Rovira J, Ortun V, García-Alonso F, Prieto L, Antonanzas F; Grupo ECOMED. Utilización de las evaluaciones económicas de intervenciones sanitarias. Med Clin (Barc). 2004;122:789-95.
13. Task Force on Community Preventive Services. En: Zaza S, Briss PA, Harris KW, editors. The guide to community preventive services. What works to promote health? New York: Oxford University Press; 2005.
14. Pharmacoeconomic Guidelines Around the World. Disponible en: http:// www.ispor.org/PEguidelines/index.asp
15. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
16. Drummond MF, Jefferson TO, for the BMJ Working Party on Guidelines for Authors and Peer-Reviewers of Economic Submissions to the British Medical Journal. Guidelines for authors and peer-reviewers of economic submissions to the British Medical Journal. BMJ 1996;313:275-383.
17. Kassirer JP, Angel M. The journal's policy on cost-effectiveness analyses. N Engl J Med. 1994;331:669-70.
18. Fernéndez E. Gaceta Sanitaria 2005: seguimos en la brecha. Gac Sanit. 2006;20:9-13.
19. Graham JD, Corso PS, Morris JM, Segui-Gómez M, Weinstein MC. Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health. 1998;19:125-52.